Evotec Email Format
Biotechnology ResearchHamburg, Germany1001-5000 Employees
Evotec is a biotechnology firm focused on accelerating drug discovery and development. It collaborates with pharmaceutical companies, biotechs, foundations, and government agencies through flexible, large-scale partnerships to advance projects across the full drug development spectrum. Its Pipeline Co-Creation model combines multi-modality, end-to-end workstreams—from target discovery to clinical proof of concept and manufacturing—into integrated programs. Based in Hamburg, Germany, Evotec provides data-driven disease understanding and AI-enabled insights to improve the odds of clinical success, delivering integrated R&D portfolios and individual projects for biopharma partners. A notable 2026 development is the appointment of Rui Wang as Executive Vice President, Head of Global In Silico and AI, underscoring the emphasis on AI-assisted drug discovery.